| COMPOSITION | GLIMEPRIDE...1MG,PIOGLITAZONE...7.5MG,METFORMIN(SR)...500MG |
| Packing | 10X10,10X15 |
| Uses | Produces dual check on the progress of diabetes mellitus, Blessed with Multiple Antidiabetic Effects of Metformin, Ensures Built-In Better Lipid Profile of Metformin and Pioglitazone, Helps Preventing Cardiovascular Manifestations of Insulin Resistance |
| Indication | INSULIN-RESISTANT DIABETES MELLITUS, PREVENTION OF ASSOCIATED MACROVASCULAR AND MICROVASCULAR COMPLICATIONS |
| Key Ingrediants | GLIMEPIRIDE 1MG, METFORMIN 500MG (SR), PIOGLITAZONE 7.5MG TABLET |
| PRODUCT DISCRIPTION | Glimepiride , metformin and pioglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin. Pioglitazone is a thiazolidinedione which further increases insulin sensitivity. |